Why this matters: Despite being extremely common, multiple chronic conditions attract surprisingly little attention, data or funding. Building on evidence presented alongside the UN General Assembly, this piece argues why the health community can no longer afford to treat diseases one at a time.
Yet the response from the health community is non-commensurate. In our 2017 overview of the burden from MCCs, presented at a World Economic Forum event in September 2017 alongside the United Nations General Assembly, we concluded that despite MCCs being so prevalent, there is a dearth of information on their prevalence, clustering, cost and patient burden. 3A 2018 systematic review published in BMJ Global Health by Sum et al aimed to quantify out-of-pocket expenditure (OOPE) on medicines in patients with MCCs. 4 Using the context of the findings from Sum et al, we argue why MCCs warrant specific focus by the health community.
